Abstract
ObjectivesTreatment targets in systemic lupus erythematosus (SLE) have been validated in unselected—in terms of severity—cohorts, which limits their generalisability. We assessed remission (Definition of Remission in SLE (DORIS)) and Lupus...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have